Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subanesthetic esketamine to prevent emergence agitation after orthognathic surgery
ChiCTR2400080566Phase 4Not yet recruiting
- Sponsor
- Peking University School of Stomatology
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in Emergence agitation (EA) (2 arms), sponsored by Peking University School of Stomatology. Primary endpoint: Incidence of emergence agitation. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on ChiCTR2400080566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080566.